These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 19963354

  • 1. Colorimetric analysis of unstained lesions surrounding oral squamous cell carcinomas and oral potentially malignant disorders using iodine.
    Maeda K, Suzuki T, Ooyama Y, Nakakuki K, Yamashiro M, Okada N, Amagasa T.
    Int J Oral Maxillofac Surg; 2010 May; 39(5):486-92. PubMed ID: 19963354
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The clinicopathologic significance of small areas unstained by Lugol's iodine in the mucosa surrounding resected esophageal carcinoma: an analysis of 147 cases.
    Nakanishi Y, Ochiai A, Yoshimura K, Kato H, Shimoda T, Yamaguchi H, Tachimori Y, Watanabe H, Hirohashi S.
    Cancer; 1998 Apr 15; 82(8):1454-9. PubMed ID: 9554520
    [Abstract] [Full Text] [Related]

  • 4. Clinical evaluation of Lugol's iodine staining in the treatment of stage I-II squamous cell carcinoma of the tongue.
    Umeda M, Shigeta T, Takahashi H, Minamikawa T, Komatsubara H, Oguni A, Shibuya Y, Komori T.
    Int J Oral Maxillofac Surg; 2011 Jun 15; 40(6):593-6. PubMed ID: 21334851
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions.
    Nagaraju K, Prasad S, Ashok L.
    Indian J Dent Res; 2010 Jun 15; 21(2):218-23. PubMed ID: 20657091
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of double vital staining with lugol's iodine and methylene blue in diagnosing superficial esophageal lesions.
    Peng G, Long Q, Wu Y, Zhao J, Chen L, Li X.
    Scand J Gastroenterol; 2011 Apr 15; 46(4):406-13. PubMed ID: 21189106
    [Abstract] [Full Text] [Related]

  • 7. Use of Lugol's iodine in the resection of oral and oropharyngeal squamous cell carcinoma.
    McMahon J, Devine JC, McCaul JA, McLellan DR, Farrow A.
    Br J Oral Maxillofac Surg; 2010 Mar 15; 48(2):84-7. PubMed ID: 20031284
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term treatment outcome of oral premalignant lesions.
    Holmstrup P, Vedtofte P, Reibel J, Stoltze K.
    Oral Oncol; 2006 May 15; 42(5):461-74. PubMed ID: 16316774
    [Abstract] [Full Text] [Related]

  • 10. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China.
    Dawsey SM, Fleischer DE, Wang GQ, Zhou B, Kidwell JA, Lu N, Lewin KJ, Roth MJ, Tio TL, Taylor PR.
    Cancer; 1998 Jul 15; 83(2):220-31. PubMed ID: 9669803
    [Abstract] [Full Text] [Related]

  • 11. Re: use of Lugol's iodine in oral cancer diagnosis: an overview.
    Kanatas A, McCaul JA.
    Oral Oncol; 2010 Nov 15; 46(11):835; author reply 836. PubMed ID: 20947412
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Histopathological evaluation including cytokeratin 13 and Ki-67 in the border between Lugol-stained and -unstained areas.
    Ohta K, Ogawa I, Ono S, Taki M, Mizuta K, Miyauchi M, Takechi M, Shigeishi H, Takata T, Kamata N.
    Oncol Rep; 2010 Jul 15; 24(1):9-14. PubMed ID: 20514438
    [Abstract] [Full Text] [Related]

  • 14. Cell proliferation and tumour suppressor gene expression in iodine unstained area surrounding oral squamous cell carcinoma.
    Yokoo K, Noma H, Inoue T, Hashimoto S, Shimono M.
    Int J Oral Maxillofac Surg; 2004 Jan 15; 33(1):75-83. PubMed ID: 14690663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinicopathologic correlations of oral premalignant lesions and squamous cell carcinomas.
    Kootman J, El-Mofty SK.
    J Mo Dent Assoc (1980); 1982 Jan 15; 62(6):33-5. PubMed ID: 6961228
    [No Abstract] [Full Text] [Related]

  • 17. Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study.
    Chen HH, Chen IH, Liao CT, Wei FC, Lee LY, Huang SF.
    Clin Otolaryngol; 2011 Apr 15; 36(2):147-53. PubMed ID: 21332670
    [Abstract] [Full Text] [Related]

  • 18. The role of vital tissue staining in the marginal control of oral squamous cell carcinoma.
    Kerawala CJ, Beale V, Reed M, Martin IC.
    Int J Oral Maxillofac Surg; 2000 Feb 15; 29(1):32-5. PubMed ID: 10691141
    [Abstract] [Full Text] [Related]

  • 19. Use of Lugol's iodine in oral cancer diagnosis: an overview.
    Petruzzi M, Lucchese A, Baldoni E, Grassi FR, Serpico R.
    Oral Oncol; 2010 Nov 15; 46(11):811-3. PubMed ID: 20729139
    [Abstract] [Full Text] [Related]

  • 20. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM, van der Waal I.
    J Pathol; 1998 Apr 15; 184(4):360-8. PubMed ID: 9664901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.